Immunome Inc reports results for the quarter ended in March - Earnings Summary

Immunome

12/05/2022 16:05

* Immunome Inc  IMNM.OQ  reported a quarterly adjusted loss
of 96
cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 69 cents per
share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Immunome Inc's reported EPS for the quarter was a loss
of 96
cents​.
    * The mean earnings estimate of analysts had risen by
about 33% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Immunome Inc shares had fallen by 59.5% this quarter and
lost 82.3% so far this year.
    * The company reported a quarterly loss of $11.65 million.
    * Wall Street's median 12-month price target for Immunome
Inc is
$15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 03:04 p.m.  ​All
figures in US dollars unless otherwise stated